Companies: 10,795·Total market cap: $144.5T
Trinity Biotech plc

Trinity Biotech plc

TRIBNASDAQHealthcare● Active
$0.68
+$0.01(+1.87%)
Market Cap$7063227
P/E Ratio—
52W High$3.44
52W Low$0.5
SEC Filings
Foreign Private Issuer · Files 20-F / 6-K

Trinity Biotech plc (TRIB) SEC Filings & 10-K Annual Reports

SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.

SEC EDGAR · data.sec.gov · CIK 0000888721 · TRIB · NASDAQ · as of Jun 9, 2026

Filing snapshot

475
Total Filings
6-K
Latest Form
2026-06-05
Most Recent
1992
Filing Since
FinancialsEarningsView All on EDGAR

Source: SEC EDGAR (data.sec.gov) · CIK 0000888721 · Updated hourly · Not investment advice

Latest Annual Report

20-F · Annual Report (Foreign Issuer)FY
Filed Date
2026-04-30
Fiscal Year End
Apr 30, 2026
Accession No.
0001554855-26-000848
Primary Document
trib-20251231.htm
View on SEC EDGARDownload PDFFiling Index
Source: data.sec.gov · CIK 0000888721 · Accession 0001554855-26-000848

Latest Key Filings

6-KQuarterly Report
6-K
2026-06-05
View 6-K on SEC
8-KCurrent Report

No recent filings

Form 4Insider Activity
Ownership Change Disclosures

Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.

View Insider Trades Tab

SEC Filing History

Hide Form 4 / 144
6-KCurrent Report (Foreign Issuer)
6-K
2026-06-05
View
AWAW
AW
2026-06-04
View
POS AMPOS AM
POS AM
2026-06-04
View
RWRW
FORM RW
2026-06-03
View
F-1/AF-1/A
FORM F-1/A
2026-06-03
View
424B3424B3
424B3
2026-05-26
View
EFFECTEFFECT
EFFECT
2026-05-22
View
F-3F-3
F-3
2026-05-13
View
F-3F-3
F-3
2026-05-13
View
6-KCurrent Report (Foreign Issuer)
6-K
2026-05-06
View
SCHEDULE 13D/ASCHEDULE 13D/A
SCHEDULE 13D/A
2026-05-04
View
20-FAnnual Report (Foreign Issuer)
20-F
2026-04-30
View
3Initial Statement of Beneficial Ownership
Initial Statement of Beneficial Ownership
2026-04-08
View
3/AInitial Statement of Beneficial Ownership (Amended)
Initial Statement of Beneficial Ownership (Amended)
2026-04-08
View
3Initial Statement of Beneficial Ownership
Initial Statement of Beneficial Ownership
2026-04-03
View
Showing 1–15 of 475 filingsForm 4 / 144 hidden

About SEC Filings & 10-K Annual Reports

Data source: SEC EDGAR (data.sec.gov)  |  Updated: Hourly  |  CIK: 0000888721  |  Exchange: NASDAQ · Healthcare

Trinity Biotech plc (NASDAQ: TRIB) has submitted 475 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 1992. As a Healthcare sector company with CIK 0000888721, all filings are publicly accessible via the EDGAR database at no cost.

The annual 10-K report is Trinity Biotech plc's most comprehensive regulatory disclosure. The most recent Trinity Biotech plc 10-K was filed on 2026-04-30 for fiscal year ending 2026. Historical TRIB 10-K annual reports are available from 1996 through 2026.

Investors researching Trinity Biotech plc SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.

Source: SEC EDGAR · data.sec.gov · SEC Form 10-K · SEC Form 10-Q · SEC Form 8-K2026-06-09
Related Companies SEC Filings — Healthcare
SNSE SEC Filings →MRKR SEC Filings →CHEK SEC Filings →SINT SEC Filings →EVGN SEC Filings →TNON SEC Filings →BGLC SEC Filings →ADVB SEC Filings →
→ TRIB Financials→ TRIB Earnings→ TRIB Insider Trades

Frequently Asked Questions

TRIB SEC Filings · 8 questions

Trinity Biotech plc (TRIB) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 475 filings and access original documents at no cost. Trinity Biotech plc's CIK is 0000888721.

TRIB SEC filingsTrinity Biotech plc SEC documentsfind TRIB 10-K